Kip Burgess was allayed last year when pharmaceutical monster Amgen overnighted him a $2,976 check to aid pay for his go-to arthritis medication, Enbrel.
“Nothing in countries around the world gives me more nervousnes than simply get my drug, ” Burgess said. “There’s nothing you can do but beg.”
Panicked, Burgess had called Amgen and pleaded of providing assistance. The drugmaker mailed him the check after he rendered a charge card statement and an explanation of benefits to prove he bought its drug.